Vanguard Group Inc Nkarta, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,554,282 shares of NKTX stock, worth $5.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,554,282

Previous 2,525,107 1.16%

Holding current value

$5.01 Million

Previous $4.65 Million 8.74%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$1.51 - $2.22 $44,054 - $64,768	29,175 Added 1.16%	2,554,282 $4.24 Million
Q1 2025 May 09, 2025	SELL	$1.37 - $2.53 $7,772 - $14,352	-5,673 Reduced 0.22%	2,525,107 $4.65 Million
Q4 2024 Feb 11, 2025	SELL	$2.17 - $4.34 $1.04 Million - $2.08 Million	-479,160 Reduced 15.92%	2,530,780 $6.3 Million
Q3 2024 Nov 13, 2024	BUY	$4.52 - $8.0 $242,118 - $428,528	53,566 Added 1.81%	3,009,940 $13.6 Million
Q2 2024 Aug 13, 2024	BUY	$5.27 - $10.82 $5.22 Million - $10.7 Million	990,103 Added 50.35%	2,956,374 $17.5 Million
Q1 2024 May 10, 2024	BUY	$5.59 - $15.71 $2.27 Million - $6.37 Million	405,753 Added 26.0%	1,966,271 $21.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $80,929 - $407,734	61,778 Added 4.12%	1,560,518 $10.3 Million
Q3 2023 Nov 14, 2023	SELL	$1.39 - $2.29 $17,976 - $29,616	-12,933 Reduced 0.86%	1,498,740 $2.08 Million
Q2 2023 Aug 14, 2023	SELL	$2.19 - $5.17 $42,908 - $101,295	-19,593 Reduced 1.28%	1,511,673 $3.31 Million
Q1 2023 May 15, 2023	BUY	$3.37 - $6.3 $400,591 - $748,881	118,870 Added 8.42%	1,531,266 $5.44 Million
Q4 2022 Feb 10, 2023	BUY	$5.14 - $14.35 $274,316 - $765,845	53,369 Added 3.93%	1,412,396 $8.46 Million
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $318,001 - $476,613	25,917 Added 1.94%	1,359,027 $17.9 Million
Q2 2022 Aug 12, 2022	BUY	$7.77 - $19.44 $5.48 Million - $13.7 Million	705,393 Added 112.37%	1,333,110 $16.4 Million
Q1 2022 May 13, 2022	SELL	$8.66 - $14.99 $2.91 Million - $5.04 Million	-336,372 Reduced 34.89%	627,717 $7.14 Million
Q4 2021 Feb 14, 2022	SELL	$12.79 - $26.88 $2.61 Million - $5.5 Million	-204,435 Reduced 17.5%	964,089 $14.8 Million
Q3 2021 Nov 12, 2021	BUY	$26.67 - $38.76 $958,226 - $1.39 Million	35,929 Added 3.17%	1,168,524 $32.5 Million
Q2 2021 Aug 13, 2021	BUY	$23.94 - $36.68 $27.1 Million - $41.5 Million	1,132,595 New	1,132,595 $35.9 Million

Others Institutions Holding NKTX

# of Institutions

119

Shares Held

61.5M

Call Options Held

13.7K

Put Options Held

10.3K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $95.4M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Nkarta, Inc. Transaction History